Table 5 Distribution of parasite phenotype and genotypes in day-3 positive parasites.

From: Artemisinin combination therapy fails even in the absence of Plasmodium falciparum kelch13 gene polymorphism in Central India

 > 72 h (+) case

Plasma artesunate (nmol/L)

Parasite load on day-0 pd/µL

Parasite load on day-3 pd/µL

Fever on day 0 (°C)

Fever on day 3 (°C)

RSA(0–3 h) (in %)

Treatment response (in h)

Kelch13 genotype

Atpase6 haplotype

Pfmdr1 haplotype

Pfcrt haplotype

 

1.5 h

3 h

     

PCT

PC1/2

    

Case1

4023

2361

19,368

237

39.6

38.1

2.4

96

6.2

Wild

LEAAS

YYSND

SVMNTNT

Case 2

4196

2147

8432

96

38.5

38

3.0

102

5.6

Wild

LEAAS

YFSND

CVIETNT

Case 3

3833

2051

21,641

356

38.7

38.1

2.1

108

5.6

Wild

LEAAS

YFSND

SVMNTST

Case 4

4077

1952

70,846

611

38.4

37.8

2.6

108

5.8

Wild

LEAAS

YFSND

SVMNTST

Case 5

4086

2052

56,855

123

38.8

37.5

1.7

96

5.3

Wild

LEAAS

YFSND

SVMNTST

Case 6

3981

2114

11,790

202

40.3

38.2

3.3

120

5.9

Wild

LEEAS

YFSND

SVMNTNT

Case 7

3591

1805

44,181

728

39.8

37.9

102

5.7

Wild

LEEAS

YFSND

SVMNTNT

Case 8

955

548

9716

455

38

37.5

0.9

108

5.7

Wild

LEAAS

YYSND

SVMNTST

Case 9

4258

2104

36,847

107

39.5

38

2

114

5.5

Wild

LEAAS

YFSND

CVIETNT

  1. PCT represented Parasite clearance time (in h) and parasite clearance half-life was denoted as PC1/2 (in h). We have presented parasite density as PD. Individual ex-vivo ring stage survivability of parasite isolates was represented as RSA(0–3 h). Underline codons were mutant codon. In case 8, RSA(0–3 h) was recorded 0.94% with PC1/2 of 5.7 h while case 7 was failed to culture adaptation. The day-3 parasite load was ranging from 1.8 to 14.2% from that of day-0 parasitaemia.